SC-236 is an orally bioavailable inhibitor of COX-2. SC-236 exhibits anti-inflammatory properties and potent antimetastatic activity against both experimental metastases and spontaneous metastases arising following primary tumor excision. References: Kishi K, Milas L, Hunter N, Sato M. [Recent studies on anti-angiogenesis in cancer therapy]. Nihon Rinsho. 2000 Aug;58(8):1747-62. Review. Japanese. PubMed PMID: 10944947.

纯度：≥98%

CAS：170569-86-5